{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362262944523402880.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1186/s13046-018-0694-6"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1186/s13046-018-0694-6.pdf"}}],"dc:title":[{"@value":"14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382262944523402885","@type":"Researcher","foaf:name":[{"@value":"Jing Luo"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944523402883","@type":"Researcher","foaf:name":[{"@value":"Jian-Feng Yao"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944523402887","@type":"Researcher","foaf:name":[{"@value":"Xiao-Fei Deng"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944523402881","@type":"Researcher","foaf:name":[{"@value":"Xiao-Dan Zheng"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944523402886","@type":"Researcher","foaf:name":[{"@value":"Min Jia"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944523402882","@type":"Researcher","foaf:name":[{"@value":"Yue-Qin Wang"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944523402884","@type":"Researcher","foaf:name":[{"@value":"Yan Huang"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944523402880","@type":"Researcher","foaf:name":[{"@value":"Jian-Hua Zhu"}]}],"publication":{"publicationIdentifier":[{"@type":"EISSN","@value":"17569966"}],"prism:publicationName":[{"@value":"Journal of Experimental & Clinical Cancer Research"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2018-02-09","prism:volume":"37","prism:number":"1","prism:startingPage":"23"},"reviewed":"false","url":[{"@id":"http://link.springer.com/content/pdf/10.1186/s13046-018-0694-6.pdf"}],"createdAt":"2018-02-09","modifiedAt":"2020-10-28","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360021389817717120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Molecular Networks of Platinum Drugs and Their Interaction with microRNAs in Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617624290816","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869854363302656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Integrins in Cancer Drug Resistance: Molecular Mechanisms and Clinical Implications"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1186/s13046-018-0694-6"},{"@type":"CROSSREF","@value":"10.3390/genes14112073_references_DOI_GxBMTUWfYw8iHPV41fuCmlVwKKS"},{"@type":"CROSSREF","@value":"10.1186/s12885-020-07717-0_references_DOI_GxBMTUWfYw8iHPV41fuCmlVwKKS"},{"@type":"CROSSREF","@value":"10.3390/ijms26073143_references_DOI_GxBMTUWfYw8iHPV41fuCmlVwKKS"}]}